NCT01987193

Brief Summary

The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2013

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 19, 2013

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

May 29, 2018

Status Verified

May 1, 2018

Enrollment Period

5.8 years

First QC Date

October 24, 2013

Last Update Submit

May 24, 2018

Conditions

Brain CancerProstate CancerLung Cancer

Keywords

Proton radiationtumor blood flow

Outcome Measures

Primary Outcomes (1)

  • Patients with hypoxic tumor identified by tumor blood flow measurement.

    3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients treated at radiation oncology clinic

You may qualify if:

  • Solid tumors in the intracranial, thoracic, or pelvic regions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida Proton Therapy Institute

Jacksonville, Florida, 32206, United States

Location

MeSH Terms

Conditions

Brain NeoplasmsProstatic NeoplasmsLung Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Zhong Su, PhD

    University of Florida Proton Therapy Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2013

First Posted

November 19, 2013

Study Start

July 1, 2012

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

May 29, 2018

Record last verified: 2018-05

Locations

US(1)